drugset / Trial / NCT03781674

Role of 200 mg Versus 400mg Vaginal Progesterone in Prevention of Preterm Labor in Twin Gestation

NCT03781674

Unknown 200 enrolled Aswan University Hospital
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The objective of the present study is to evaluate the effectiveness of two doses of vaginal progesterone(200mg versus400mg) and placebo in improving gestational age in twin pregnancy and its subsequent impact on perinatal outcome.

Timeline

Start
2019-01-01
Primary completion
2021-12-31
Completion
2022-03-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Progesterone Other / unclassified 200 mg Other
Comparator Progesterone Other / unclassified 400 mg Other